Crossmark

MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy

Crossref DOI link: https://doi.org/10.1186/s40644-022-00474-2

Published Online: 2022-07-16

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Xiaomiao

Zhao, Jingwei

Zhang, Qi

Wang, Sicong

Zhang, Jieying

An, Jusheng

Xie, Lizhi

Yu, Xiaoduo

Zhao, Xinming http://orcid.org/0000-0003-2658-6399
License Information

Text and Data Mining valid from 2022-07-16

Version of Record valid from 2022-07-16
More Information

Article History

Received: 22 March 2022

Accepted: 6 July 2022

First Online: 16 July 2022

Declarations

:

: The study was approved by the Ethics Committee of National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College. The informed consent was waived by the Ethics Committee.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below